TB-3417 · REV A · Technical newsheet
Test & MeasurementDevice profile
Biota Adds 120Water Founder and Burnt Island Partner to Board After $3M Seed
Biota adds 120Water founder Megan Glover and Burnt Island's Steve Kloos to its board after a $3M seed round as it prepares to commercialize sub-hour field PFAS testing.
By Amara Osei3 min read640 words
Features
- Biota appointed Megan Glover and Steve Kloos, PhD, to its board of directors.
- The appointments follow a $3 million seed financing led by Burnt Island Ventures.
- Biota's patent-pending platform targets PFAS detection in under one hour.
- CEO Rose Nash, PhD, said the focus is now bringing the technology to market.
- Target customers are water utilities, treatment operators, and environmental service providers.

Biota Inc., a Longmont, Colorado environmental diagnostics company, has appointed Megan Glover, founder of 120Water, and Steve Kloos, PhD, partner at Burnt Island Ventures, to its board of directors following a $3 million seed financing round led by Burnt Island Ventures.
The board changes land as the company prepares to commercialize a field-deployable testing platform designed to detect per- and polyfluoroalkyl substances (PFAS, a group of persistent chemicals used in industrial and consumer products) in under an hour. That figure is a design target, not a measured result — Biota has published no independent validation data, accuracy figures, or detection limits alongside the announcement. Buyers will want both before trusting a field screen against laboratory methods.
Why sub-hour PFAS testing matters
Current PFAS analysis typically requires sending samples to certified laboratories, with turnaround times measured in days or weeks. For water treatment operators and environmental professionals, that lag slows decisions about contamination response, treatment adjustment, and regulatory reporting.
Biota's pitch is straightforward: portable instrumentation, actionable results in less than an hour, and lower cost per test. The company says the technology supports faster decisions about water treatment and environmental monitoring. The physics and chemistry behind the patent-pending platform remain undisclosed, which is standard at this stage but also means the claims rest entirely on vendor description. The one performance claim with substance is Kloos's statement that the technology "performs in challenging real-world samples" — matrix tolerance being the usual graveyard of rapid PFAS methods.
Who joined the board
Glover currently serves as chief digital officer at USALCO and previously founded 120Water, a water quality technology company serving utilities, government agencies, and water industry professionals nationwide. Her track record covers building and scaling water technology businesses, developing commercial strategies, and helping customers adopt new tools.
Kloos holds a doctorate in chemistry and brings scientific research, technology commercialization, and venture investing experience, including previous leadership roles at GE Water. His appointment also formalizes the investor relationship: Burnt Island Ventures, a venture capital firm specializing in water technology, led the seed round.
What the principals said
"We've built a strong scientific foundation and demonstrated the need for a fundamentally faster approach to PFAS testing," said Rose Nash, PhD, founder and CEO of Biota. "Now our focus is on bringing that technology to market and scaling its impact. Megan has successfully navigated the exact stage of growth we're entering, while Steve brings an exceptional combination of scientific depth, intellectual property expertise, and investment experience."
Kloos framed the investment thesis around the testing bottleneck. "PFAS is an enormous environmental problem, and one of the biggest issues is the lack of timely, affordable testing," he said. "What drew us to Biota was their customer-first approach and differentiated, patent-pending technology that performs in challenging real-world samples."
Glover, for her part, pointed at the sector's adoption habits. "Building a successful company in the water industry takes more than great technology," she said. "It requires a deep understanding of customers and how to bring innovation into an industry that has historically been slow to adopt."
That observation is the correct one. Water utilities buy on reliability, compliance standing, and lifecycle cost, not demo-day enthusiasm.
What happens next
With seed financing closed and the board expanded, Biota says it is focusing on moving the patent-pending platform toward commercial deployment and expanding adoption among water utilities, treatment operators, and environmental service providers.
The open question is regulatory acceptance. PFAS monitoring for drinking water systems is tightening under environmental regulators, and any field-deployable screen will need to demonstrate equivalence or fit a defined screening role beside certified laboratory methods. Until Biota publishes detection limits, cross-reactivity data, and validation against reference methods, the sub-hour claim is a roadmap item. The market, and the regulators, will want the numbers.
via citybiz.co (Source)
Filed under
- pfas-testing
- water-quality-testing
- environmental-diagnostics
- rapid-testing
- field-deployable-instrumentation
More from Amara Osei
Show full bio
Senior reporter covering people, launches and day-to-day practice in Instruments, test and measurement at Testbench Report.
124 articles
Application notes
- SEPRO Buys Bend Genetics, Adding West Coast Algal Bloom Lab
- Biomatter Closes $18M Series A to Build Enzyme Design Facility
- Merck KGaA to Buy Rapid Micro Biosystems at $0.75 Per Share
- Dual-Channel Fluorescence Sensor Sorts Microplastics at 77.8% Accuracy
- UNDP and Sri Lanka's Environment Ministry Deliver Lab Equipment for Chemicals Management